Details of the Drug Formulaction

General Information of Drug Formulation (ID: F12691)

• Formulation Name: Lubiprostone 0.024 mg capsule
• Company: Takeda Pharmaceuticals America

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Lubiprostone	(DMJTEMW)	Chronic idiopathic constipation	DC32	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Allura red AC dye	(E00338)	33258	Colorant
Hexahydric alcohol	(E00083)	5780	Diluent; Flavoring agent; Humectant; Plasticizing agent
Medium-chain triglyceride	(E00640)	Not Available	Emollient; Lubricant; Surfactant
Quinoline yellow WS	(E00309)	24671	Colorant
Water	(E00035)	962	Solvent